Nanocopoeia is a drug delivery company developing a nanotechnology-enabled portfolio of therapeutic products. Nanocopoeia Inc. has developed a novel electrospray system for the production of nanoparticles. The business of Nanocopoeia is the therapeutic use of those nanoparticles in medical applications. Our patented ElectroNanospray™ (ENS) process is currently being used to produce complex coatings for medical devices and to nanoformulate drugs for enhanced bioavailability. Our business model is to enhance the value and performance of off-patent, already-proven drugs by creating novel nanoformulations optimized for delivery into and through the skin and providing medical device coating services and equipment. Our two lead drug products target the chronic, inadequately controlled clinical conditions of pain and acne.